Kailera Therapeutics Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
21:56
Apr 19
Apr 19
Peptide obesity theme benefits Hims Kailera
RFK Jr.'s push to ease peptide restrictions is seen as a benefit to Hims & Hers because it had acquired related facilities. The speaker also notes that obesity-treatment company Kailera Therapeutics surged about 60% on its listing, showing continued interest in the theme.
MED
About Kailera Therapeutics Investor Commentary
Across the available history and selected sources, Buzzberg tracks Kailera Therapeutics across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Park Myung-sung.